Value proposition

Multi-Omics for Translational Cancer Research

OmicsChart is a computational cancer biology startup revolutionising translational cancer research with our proprietary multi-omics cancer biomarker discovery platform. Our platform enables rapid access and analysis of harmonised biomarker data for 35 cancer indications through domain-specific AI and machine learning, reducing data acquisition and analysis time by 150 times compared to current practices.

Our solution allows translational cancer scientists to quickly test hypotheses and extract insights from a harmonised mix of public and proprietary biomarker data. Built on federated data integration and domain-driven ML/AI, our platform features biologist-friendly scientific visualisations.

We provide comprehensive insights on DNA and RNA biomarkers, immune cell composition, and single-cell tumour resolution, all integrated with clinical information. This streamlines research processes and supports patient-centric studies and oncology drug development.

Our mission is to create an integrated ecosystem that simplifies oncology research, accelerating the discovery of new cancer therapies and improving patient outcomes.

For more information on how OmicsChart can support your research, visit our website at www.omicschart.com.

Bioinformatics, Data Science, Precision oncology, NGS, RNAseq, and Multi-omics